Diabetic Cheiroarthropathy

Poll

Which of the following statements about diabetic cheiroarthropathy are true?

Diabetic cheiroarthropathy is defined by stiffness of the hands and flexion contractures seen in patients with long-standing type 1 DM, as well as with type 2 DM.

Which of the following statements about this condition are true?

A. It is characterized by thick, waxy skin associated with sclerosis of tendon sheaths.
B. It often results in the "prayer sign."
C. Accumulation of collagen in skin and flexor tendons in DM can lead to loss of full extension of the fingers.
D. There is no specific treatment for diabetic cheiroarthropathy.
E. All of the above are true.
Related Videos
Laxmi Mehta, MD | Credit: American Heart Association
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
Erin Michos, MD | Credit: Johns Hopkins University
Natalie McCormick, PhD | Credit: American College of Rheumatology
Related Content
Brendon Neuen, MBBS, PhD | Credit: X.Com

SMART-C Meta-Analysis: SGLT2 Inhibitors Reduce Cardiovascular Events

April 18th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Manufacturing Costs for Diabetes Medicines Could Likely Be Lower | Image Credit: Harvard University

Manufacturing Costs for Diabetes Medicines Could Likely Be Lower, Study Finds

April 4th 2024
Article
Diabetes Dialogue: Hot Topics and Updates from ATTD 2024

Diabetes Dialogue: Hot Topics and Updates from ATTD 2024

March 30th 2024
Podcast
Credit: US Food and Drug Administration

Semaglutide (Wegovy) Receives FDA Label Expansion to Include Cardiovascular Risk Reduction

March 8th 2024
Article
Stock imagery of a body weight scale. | Credit: iStock

Novo Nordisk Delivers Updates on Development of Semaglutide, CagriSema, Amycretin, and More

March 7th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.